REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Fg Pharma Private Limited (India)

Main Activities: Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
Full name: Fg Pharma Private Limited Profile Updated: May 18, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Fg Pharma Private Limited is an unlisted company, incorporated on 23/04/2011. It has its registered office in the State of Tamil Nadu, India. Company's corporate identification number (CIN) is U33100TN2011PTC080270 and registration number is 080270. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Old No.4, New No.75A, Janakpuri 1St Street, Sankaran Avenue,Velachery Bypass Road, Velachery
Chennai; Tamil Nadu; Postal Code: 600042

Contact Details: Purchase the Fg Pharma Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Fg Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Fg Pharma Private Limited report to view the information.
Incorporation Date:
April 23, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
65%
Purchase this report to view the information.
29.71%
Company Performance
Financial values in the chart are available after Fg Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-53.69%▼
Total operating revenue
-53.67%▼
Operating profit (EBIT)
-63.28%▼
EBITDA
-60.68%▼
Net Profit (Loss) for the Period
-62.73%▼
Total assets
-17.35%▼
Total equity
4.95%▲
Operating Profit Margin (ROS)
-0.96%▼
Net Profit Margin
-0.81%▼
Return on Equity (ROE)
-8.83%▼
Quick Ratio
2.53%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo